Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature.

Magdalena Banaszak-Ziemska, Aleksandra Rojek, Marek Niedziela
{"title":"Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature.","authors":"Magdalena Banaszak-Ziemska, Aleksandra Rojek, Marek Niedziela","doi":"10.5603/ep.100030","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Short stature is one of the main reasons for consultation in outpatient clinics and paediatric endocrinology departments and is defined as height below the 3rd centile or less than -2 standard deviations (SDs).</p><p><strong>Material and methods: </strong>The study's overarching aim was to analyse the PAPP-A2 gene at mutation sites described to date and at exons 3, 4, and 5, which encode the fragment of the catalytic domain with the active site of the pregnancy-associated plasma protein A2 (PAPP-A2) protein. The secondary aims of the study were clinical and auxological analysis of a group of patients with idiopathic short stature and biochemical analysis of growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis parameters not assessed as part of the routine diagnosis of short stature, such as free IGF-1, insulin-like growth factor binding protein 5 (IGFBP-5), and acid-labile subunit (ALS) levels. Molecular analysis of the PAPP-A2 gene was performed using polymerase chain reaction (PCR) and direct sequencing. Biochemical analysis of free IGF-1, IGFBP-5, and ALS was performed by enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>The mean height standard deviation score (HSDS) in the study group was -2.95. None of the patients exhibited previously described mutations in the PAPP-A2 gene or mutations in exons 3, 4, and 5 encoding the fragment of catalytic domain with the active site of the PAPP-A2 protein. In 4 patients, the known, non-pathogenic, heterozygotic polymorphism c.2328C>T(rs10913241) in exon 5 was found.</p><p><strong>Conclusions: </strong>Free IGF-1 levels correlate better with height and HSDS than total IGF-1 levels. The previously described mutations in the PAPP-A2 gene and mutations in exons 3, 4, and 5 encoding the fragment of catalytic domain with the active site of the PAPP-A2 protein were not detected; only the known and non-pathogenic, heterozygotic polymorphism c.2328C>T(rs10913241) in exon 5 of the PAPP-A2 gene was observed.</p>","PeriodicalId":93990,"journal":{"name":"Endokrynologia Polska","volume":"75 4","pages":"428-437"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ep.100030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Short stature is one of the main reasons for consultation in outpatient clinics and paediatric endocrinology departments and is defined as height below the 3rd centile or less than -2 standard deviations (SDs).

Material and methods: The study's overarching aim was to analyse the PAPP-A2 gene at mutation sites described to date and at exons 3, 4, and 5, which encode the fragment of the catalytic domain with the active site of the pregnancy-associated plasma protein A2 (PAPP-A2) protein. The secondary aims of the study were clinical and auxological analysis of a group of patients with idiopathic short stature and biochemical analysis of growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis parameters not assessed as part of the routine diagnosis of short stature, such as free IGF-1, insulin-like growth factor binding protein 5 (IGFBP-5), and acid-labile subunit (ALS) levels. Molecular analysis of the PAPP-A2 gene was performed using polymerase chain reaction (PCR) and direct sequencing. Biochemical analysis of free IGF-1, IGFBP-5, and ALS was performed by enzyme-linked immunosorbent assay (ELISA).

Results: The mean height standard deviation score (HSDS) in the study group was -2.95. None of the patients exhibited previously described mutations in the PAPP-A2 gene or mutations in exons 3, 4, and 5 encoding the fragment of catalytic domain with the active site of the PAPP-A2 protein. In 4 patients, the known, non-pathogenic, heterozygotic polymorphism c.2328C>T(rs10913241) in exon 5 was found.

Conclusions: Free IGF-1 levels correlate better with height and HSDS than total IGF-1 levels. The previously described mutations in the PAPP-A2 gene and mutations in exons 3, 4, and 5 encoding the fragment of catalytic domain with the active site of the PAPP-A2 protein were not detected; only the known and non-pathogenic, heterozygotic polymorphism c.2328C>T(rs10913241) in exon 5 of the PAPP-A2 gene was observed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对一组 22 名特发性矮身材患者的 PAPP-A2 基因进行遗传分析,并评估游离 IGF-1、IGFBP-5 和 ALS 的浓度。
简介:身材矮小是门诊和儿科内分泌科就诊的主要原因之一,其定义是身高低于第 3 百分位数或低于-2 标准差(SDs):该研究的主要目的是分析 PAPP-A2 基因迄今为止描述的突变位点以及第 3、4 和 5 号外显子,这些外显子编码妊娠相关血浆蛋白 A2(PAPP-A2)蛋白具有活性位点的催化结构域片段。该研究的次要目的是对一组特发性矮身材患者进行临床和辅助诊断分析,并对矮身材常规诊断中未评估的生长激素-胰岛素样生长因子-1(GH-IGF-1)轴参数(如游离 IGF-1、胰岛素样生长因子结合蛋白 5(IGFBP-5)和酸性亚基(ALS)水平)进行生化分析。采用聚合酶链反应(PCR)和直接测序法对 PAPP-A2 基因进行了分子分析。通过酶联免疫吸附试验(ELISA)对游离 IGF-1、IGFBP-5 和 ALS 进行了生化分析:研究组的平均身高标准偏差评分(HSDS)为-2.95。所有患者均未出现先前描述过的 PAPP-A2 基因突变或编码 PAPP-A2 蛋白活性位点催化结构域片段的第 3、4 和 5 号外显子突变。在4名患者中,发现了第5外显子中已知的、非致病性的杂合多态性c.2328C>T(rs10913241):结论:与总 IGF-1 水平相比,游离 IGF-1 水平与身高和 HSDS 的相关性更好。未检测到之前描述的 PAPP-A2 基因突变以及编码 PAPP-A2 蛋白活性位点催化结构域片段的第 3、4 和 5 号外显子的突变;只观察到 PAPP-A2 基因第 5 号外显子上已知的非致病性杂合子多态性 c.2328C>T(rs10913241)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
0
期刊最新文献
miR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression. When lymphadenopathy is not what it seems - coexistence of mantle cell lymphoma and pancreatic neuroendocrine tumor. Evaluation of incretin levels in patients with prolactinoma. Prognostic value of lncRNA HCG4 in thyroid cancer and its regulatory effect on tumor progression. A comprehensive analysis of the impact of low AMH on ART outcomes in young patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1